Mastering Cardiology for FNP Boards: Essential Concepts & Clinical Pearls

Cardiology · 6 min read · July 15, 2026

Mastering Cardiology for FNP Boards: Essential Concepts & Clinical Pearls

Hello future FNPs! Cardiology can feel like a mountain of information, but don't let it overwhelm you. It's a critical, high-yield area for both the AANP and ANCC board exams, and understanding the core concepts will not only help you pass but also prepare you for real-world practice. We're going to break down some of the most important cardiology topics, focusing on what you absolutely need to know to confidently answer those board questions.

1. Heart Failure: Understanding the Basics and Management

Heart failure (HF) is a complex syndrome, not a disease itself, where the heart can't pump enough blood to meet the body's needs. On your boards, you'll need to differentiate between its types and understand the management principles.

Types of Heart Failure:

Heart Failure with Reduced Ejection Fraction (HFrEF): Also known as systolic heart failure. The left ventricle can't pump blood out effectively. Ejection Fraction (EF) is typically <40%. Think of a weak pump.
Heart Failure with Preserved Ejection Fraction (HFpEF): Also known as diastolic heart failure. The left ventricle can't relax and fill properly during diastole. EF is typically ≥50%. Think of a stiff pump.

Key Symptoms:

Both types can present with dyspnea (especially exertional or nocturnal), orthopnea, peripheral edema, fatigue, and weight gain. Right-sided HF often leads to systemic congestion (JVD, hepatomegaly, ascites, peripheral edema), while left-sided HF causes pulmonary congestion (crackles, S3 gallop).

Management Cornerstones:

Management focuses on improving symptoms, preventing hospitalizations, and prolonging life. For HFrEF, the mainstays are:

ACE Inhibitors/ARBs/ARNI (Angiotensin Receptor-Neprilysin Inhibitor): Reduce afterload, improve cardiac remodeling. ARNI (e.g., sacubitril/valsartan) is often preferred over ACEi/ARB in appropriate patients.
Beta-blockers (Carvedilol, Metoprolol Succinate, Bisoprolol): Reduce heart rate, improve contractility over time. Crucial point: Start low and go slow! Avoid in acute decompensated HF.
Aldosterone Antagonists (Spironolactone, Eplerenone): Reduce mortality, especially in patients with EF <35% and symptoms.
SGLT2 Inhibitors (Dapagliflozin, Empagliflozin): Newer class, shown to reduce mortality and hospitalizations in both HFrEF and HFpEF.
Diuretics (Loop diuretics like Furosemide): For symptom relief (edema, dyspnea) by reducing fluid overload. Do not improve mortality.

Clinical Pearl #1: For HFrEF, remember the 'FAB-4' for mortality reduction: Furosemide (for symptoms only), ACEi/ARB/ARNI, Beta-blockers, and Aldosterone antagonists. Now, add SGLT2 inhibitors as a critical fifth pillar! For HFpEF, management is more focused on treating underlying causes (like hypertension) and symptom control, with SGLT2 inhibitors showing significant benefit.

2. Hypertension: Diagnosis, Staging, and First-Line Treatment

Hypertension (HTN) is a silent killer and a huge topic for your boards. You need to know the diagnostic criteria and initial treatment strategies.

Diagnostic Criteria (AHA/ACC 2017 Guidelines):

Normal: <120/80 mmHg
Elevated: Systolic 120-129 mmHg AND Diastolic <80 mmHg
Stage 1 HTN: Systolic 130-139 mmHg OR Diastolic 80-89 mmHg
Stage 2 HTN: Systolic ≥140 mmHg OR Diastolic ≥90 mmHg

Diagnosis requires an average of two or more readings on two or more separate occasions.

First-Line Pharmacological Treatment for Most Adults:

Thiazide Diuretics (e.g., Hydrochlorothiazide, Chlorthalidone): Excellent first choice, especially for African American patients.
ACE Inhibitors (e.g., Lisinopril): Good for patients with diabetes, chronic kidney disease (CKD), or HF. Can cause cough and angioedema. Contraindicated in pregnancy.
Angiotensin Receptor Blockers (ARBs) (e.g., Losartan): Similar benefits to ACEIs but less cough. Contraindicated in pregnancy.
Calcium Channel Blockers (CCBs) (e.g., Amlodipine - dihydropyridine; Diltiazem - non-dihydropyridine): Dihydropyridines are good for isolated systolic HTN. Non-dihydropyridines also slow heart rate.

Clinical Pearl #2: When choosing initial HTN medication, consider comorbidities. For example, an ACEi/ARB is often preferred for patients with diabetes or CKD. For African American patients without CKD or HF, a thiazide diuretic or CCB is recommended as first-line.

3. Common Arrhythmias: Atrial Fibrillation and Supraventricular Tachycardia (SVT)

Arrhythmias can be tricky, but focusing on the most common ones and their key features will serve you well.

Atrial Fibrillation (AFib):

Characteristics: Irregularly irregular rhythm, absence of P waves, narrow QRS. The atria quiver instead of contracting effectively.
Key Risk: Stroke due to clot formation in the atria. This is why anticoagulation is crucial.
Management Goals: Rate control (beta-blockers, CCBs like diltiazem/verapamil), rhythm control (antiarrhythmics, cardioversion), and stroke prevention (anticoagulation based on CHA2DS2-VASc score).

Supraventricular Tachycardia (SVT):

Characteristics: Regular, narrow-complex tachycardia, usually with a heart rate of 150-250 bpm. P waves are often hidden within the QRS complex or T wave.
Symptoms: Palpitations, dizziness, lightheadedness, shortness of breath, anxiety.
Acute Management: Try vagal maneuvers first (Valsalva, carotid sinus massage). If unsuccessful, adenosine is the drug of choice (rapid IV push, short half-life). If unstable, synchronized cardioversion.

Clinical Pearl #3: For AFib, always assess stroke risk using the CHA2DS2-VASc score to guide anticoagulation decisions. For stable SVT, remember the treatment hierarchy: Vagal maneuvers first, then Adenosine. Unstable patients always get synchronized cardioversion.

4. Peripheral Artery Disease (PAD): Recognition and Management

PAD is a manifestation of systemic atherosclerosis, primarily affecting the lower extremities. Board questions often focus on its classic presentation and initial management.

Key Symptoms:

Intermittent Claudication: Classic symptom. Pain, cramping, or aching in the calves, thighs, or buttocks that occurs with exercise and is relieved by rest. This is a hallmark symptom.
Rest Pain: More severe PAD. Pain in the feet or toes that occurs at rest, often worse at night, and may be relieved by hanging the foot off the bed (gravity helps perfusion).
Non-healing ulcers or wounds on the lower extremities.
Physical Exam Findings: Diminished or absent peripheral pulses, pallor with elevation, dependent rubor, hair loss on legs, shiny skin, thickened toenails, cool skin temperature.

Diagnosis:

Ankle-Brachial Index (ABI): The most common and non-invasive diagnostic test. A ratio of ankle systolic pressure to brachial systolic pressure. An ABI <0.9 indicates PAD. An ABI <0.4 indicates severe PAD.

Management:

Risk Factor Modification: Crucial! Smoking cessation, aggressive management of diabetes, hypertension, and hyperlipidemia.
Antiplatelet Therapy: Aspirin or Clopidogrel (Plavix) to reduce cardiovascular events.
Exercise Program: Supervised exercise programs, especially walking, can significantly improve claudication symptoms.
Cilostazol: A phosphodiesterase inhibitor, specifically for improving claudication symptoms.

Clinical Pearl #4: The classic presentation of PAD is intermittent claudication. Remember that a normal ABI is 1.0-1.4, while an ABI <0.9 is diagnostic for PAD. Always prioritize risk factor modification and antiplatelet therapy.

Your Path to FNP Board Success

Cardiology is a vast subject, but by focusing on these high-yield topics and understanding the core principles, you're building a strong foundation for your FNP boards. Remember, confidence comes from preparation. You've got this! Keep reviewing, keep practicing, and trust in your hard work. We're here to support you every step of the way.

Ready to solidify your cardiology knowledge and conquer your FNP boards? Visit TheFNPReview.com for more resources, practice questions, and expert guidance to help you pass with flying colors.